NAUTILUS BIOTECHNOLOGY INC
NAUT·63909J108·US·Common Stock·Healthcare - Biotechnology-Activist
NAUT (NAUTILUS BIOTECHNOLOGY INC) is held by 60 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($5M), VANGUARD CAPITAL MANAGEMENT LLC ($4.8M), CITADEL ADVISORS LLC ($3.5M). Net institutional sentiment: Bullish.
60
Holders
(3 Elite)
$29.5M
Total Value
75% (64)
Consensus
48 buying - 16 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Mar 4, 2026 · Activists Aug 28, 2026 · Congress none
ActivistABAH Bio Fund II, L.P.5.6%Aug 28, 2026
ActivistPAPerceptive Advisors LLC9.1%Aug 14, 2026
ActivistABAH Bio Fund II, L.P.6.6%Jun 30, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 68
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer